Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02785068
Title Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Merrimack Pharmaceuticals

colorectal cancer


Fluorouracil + Irinotecan + Leucovorin + MM-151

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST